Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Hypermethylation of p16 and DAPK promoter gene regions in patients with non-invasive urinary bladder cancer.

Jabłonowski Z, Reszka E, Gromadzińska J, Wąsowicz W, Sosnowski M.

Arch Med Sci. 2011 Jun;7(3):512-6. doi: 10.5114/aoms.2011.23421. Epub 2011 Jul 11.

2.

Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.

Jarmalaite S, Jankevicius F, Kurgonaite K, Suziedelis K, Mutanen P, Husgafvel-Pursiainen K.

Oncology. 2008;75(3-4):145-51. doi: 10.1159/000158665. Epub 2008 Sep 29.

PMID:
18824877
3.

Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.

Liu XF, Kong FM, Xu Z, Yu SP, Sun FB, Zhang CS, Huang QX, Zhou XT, Song ZW.

Hepatobiliary Pancreat Dis Int. 2007 Aug;6(4):407-11.

4.

Methylation profiling in multiple myeloma.

Chim CS, Kwong YL, Fung TK, Liang R.

Leuk Res. 2004 Apr;28(4):379-85.

PMID:
15109538
5.

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.

Dulaimi E, Uzzo RG, Greenberg RE, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Mar 15;10(6):1887-93.

6.

Promoter hypermethylation of death-associated protein kinase and p16 genes in vulvar lichen sclerosus.

Aidé S, Lattario FR, Almeida G, do Val IC, Carvalho Mda G.

J Low Genit Tract Dis. 2012 Apr;16(2):133-9. doi: 10.1097/LGT.0b013e3182457fcc.

PMID:
22371043
7.

Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.

Chan MW, Chan LW, Tang NL, Tong JH, Lo KW, Lee TL, Cheung HY, Wong WS, Chan PS, Lai FM, To KF.

Clin Cancer Res. 2002 Feb;8(2):464-70.

8.

Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.

Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S.

Clin Cancer Res. 2005 Apr 1;11(7):2466-70.

9.

Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.

Wang W, Wang J, Li Z, Zhu M, Zhang Z, Wang Y, Jing H.

Oncol Rep. 2016 Jan;35(1):139-46. doi: 10.3892/or.2015.4347. Epub 2015 Oct 26.

PMID:
26498513
10.

Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.

Phé V, Cussenot O, Rouprêt M.

BJU Int. 2009 Oct;104(7):896-901. doi: 10.1111/j.1464-410X.2009.08696.x. Epub 2009 Jun 12. Review.

11.

Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.

Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.

Laryngoscope. 2005 Aug;115(8):1395-401.

PMID:
16094112
12.

Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer.

Valenzuela MT, Galisteo R, Zuluaga A, Villalobos M, Núñez MI, Oliver FJ, Ruiz de Almodóvar JM.

Eur Urol. 2002 Dec;42(6):622-8; discussion 628-30.

PMID:
12477660
13.

Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.

Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L.

Cancer Res. 2002 Jan 15;62(2):351-5.

14.

Promoter hypermethylation patterns of death-associated protein kinase and p16 genes in vulvar lichen sclerosus.

Aidé S, Lattario FR, Almeida G, do Val IC, Carvalho Mda G.

J Low Genit Tract Dis. 2010 Oct;14(4):282-6. doi: 10.1097/LGT.0b013e3181ec0acc.

PMID:
20885153
15.

An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer.

Tang LP, Cho CH, Hui WM, Huang C, Chu KM, Xia HH, Lam SK, Rashid A, Wong BC, Chan AO.

Digestion. 2006;74(2):85-90. Epub 2006 Nov 30.

PMID:
17139167
16.

Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions.

Millares L, Rosell A, Setó L, Sanz J, Andreo F, Monsó E.

Oncol Rep. 2014 Oct;32(4):1435-40. doi: 10.3892/or.2014.3364. Epub 2014 Jul 28.

PMID:
25069886
17.

Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.

Su Y, Xu H, Xu Y, Yu J, Xian Y, Luo Q.

Hematology. 2012 Jan;17(1):41-6. doi: 10.1179/102453312X13221316477624.

PMID:
22549447
18.

Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.

Divine KK, Pulling LC, Marron-Terada PG, Liechty KC, Kang T, Schwartz AG, Bocklage TJ, Coons TA, Gilliland FD, Belinsky SA.

Int J Cancer. 2005 Apr 10;114(3):400-5.

19.

Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.

Sun W, Zaboli D, Liu Y, Arnaoutakis D, Khan T, Wang H, Koch W, Khan Z, Califano JA.

PLoS One. 2012;7(3):e33642. doi: 10.1371/journal.pone.0033642. Epub 2012 Mar 16.

20.

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.

Cancer Res. 2002 Apr 15;62(8):2370-7.

Supplemental Content

Support Center